Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1171-1176

  Mazzariol, Annarita ^a   Koncan, Raffaella ^a   Vitali, Luca Agostino ^b   Cornaglia, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Antimicrobial resistance surveillance; Azalides; GAS; Group A streptococci; Macrolides

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; MIDECAMYCIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; HUMANS; ITALY; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 34447577820     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm089     Document Type: Article

References (13)

1. Cornaglia G, Bryskier A. Macrolide resistance of Streptococcus pyogenes. In: Pechère JC, Kaplan EL, eds. Optimal Management of Streptococcal Pharyngitis: Epidemiology, Diagnosis, Treatment and Public Health Considerations. Basel: Karger AG, 2003; 150-65.
2. Kaplan EL, Cornaglia G. Persistent macrolide resistance among group A streptococci: The lack of accomplishment after 4 decades. Clin Infect Dis 2005; 41: 609-11.
3. Cornaglia G, Ligozzi M, Mazzariol A et al. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg Infect Dis 1996; 2: 339-42.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Villanova, PA, USA, 2005.
5. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2006. http://www.sfm.asso.fr/nouv/general.php?pa=2.
6. Ono T, Shiota S, Hirota K et al. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother 2000; 44: 1078-80.
7. Seppala H, Nissinen A, Yu Q et al. Three different phenotypes of erythromycin-resistant S. pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-91.
8. Daly MM, Doktor S, Flamm R et al. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J Clin Microbiol 2004; 42: 3570-4.
9. Cocuzza C, Mattina R, Mazzariol A et al. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: An epidemiologic and molecular study. Microb Drug Res 1997; 3: 371-8.
10. Giovanetti E, Montanari MP, Marchetti F et al. In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother 2000; 46: 905-8.
11. Cantón R, Mazzariol A, Morosini M-I et al. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489-95.
12. Benvenuti C, Koncan R, Bahar G et al. Telithromycin activity is reduced by efflux in Streptococcus pneumoniae. In: Abstracts of the Sixteenth European Congress of Clinical Microbiology and Infectious Diseases, Nice, France, 2006. Abstract P1591. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
13. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 1995; 39: 797-805.